Brookfield Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Brookfield Asset Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	BUY	$700.03 - $830.35 $1.66 Million - $1.96 Million	2,366 Added 8.68%	29,626 $21.3 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $1.66 Million - $1.96 Million	2,366 Added 8.68%	29,626 $21.3 Million
Q1 2023 Sep 25, 2023	SELL	$680.49 - $826.97 $1.61 Million - $1.96 Million	-2,366 Reduced 7.99%	27,260 $22.4 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $6.36 Million - $7.73 Million	9,349 Added 52.2%	27,260 $22.4 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $2.04 Million - $2.21 Million	2,886 Added 19.21%	17,911 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $8.62 Million - $10.9 Million	15,025 New	15,025 $10.4 Million

1,493

85.8M

1.53M

1.44M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.